Latest Safety News

Page 99 of 147
Element 25 Limited advances its global manganese strategy with a $50 million loan for its Butcherbird Mine expansion and a $166 million US Department of Energy grant for a Louisiana battery-grade manganese refinery.
Maxwell Dee
Maxwell Dee
25 June 2025
Tasmea Limited forecasts a robust 34% increase in net profit after tax for FY26, driven by a record order book and strategic acquisitions, while reaffirming its FY25 earnings guidance.
Victor Sage
Victor Sage
25 June 2025
Li-S Energy has secured a collaboration and supply agreement with a leading defence technology firm to test its lithium-sulfur batteries for military applications, marking a strategic step into the global defence sector.
Sophie Babbage
Sophie Babbage
25 June 2025
Biotron Limited has completed the initial safety phase of its lead Hepatitis B drug in animal studies, paving the way for efficacy testing in two distinct mouse models. This milestone marks a significant step forward in the company’s antiviral drug development program.
Ada Torres
Ada Torres
24 June 2025
AIC Mines has secured $55 million through a well-supported placement to fund major expansions at its Eloise mine and the development of the Jericho copper project, backed by strategic investor Hawke’s Point.
Maxwell Dee
Maxwell Dee
24 June 2025
Radiopharm Theranostics has inked a clinical supply agreement with Cyclotek to support its Phase 1 trial of RAD 402, a novel radiotherapeutic targeting prostate cancer, set to commence in Australia in late 2025.
Ada Torres
Ada Torres
24 June 2025
Collins Foods Limited reported record revenue of $1.52 billion for FY25, up 2.1%, but statutory net profit plunged 88.5% due to significant impairments and wage provisions. The company declared a fully franked final dividend of 15 cents per share, signaling confidence despite challenges.
Victor Sage
Victor Sage
24 June 2025
Amplia Therapeutics has secured US ethics approval to launch a Phase 2 trial combining its drug narmafotinib with FOLFIRINOX chemotherapy for advanced pancreatic cancer, marking a key step in its clinical development.
Ada Torres
Ada Torres
24 June 2025
Virgin Australia Holdings Limited is set to list on the ASX, raising $685 million through a mix of new and existing shares, showcasing its transformation journey and strategic partnership with Qatar Airways.
Victor Sage
Victor Sage
23 June 2025
HITIQ Limited has closed its pro-rata rights issue, raising $360,426 before costs, and is now focusing on placing the remaining shortfall of shares within three months.
Sophie Babbage
Sophie Babbage
23 June 2025
Ronin Resources Limited updates ASX on delayed exploration activities and relinquished projects, citing socio-political challenges and market conditions. The company anticipates key licence grants by August 2025 and confirms compliance with listing rules while seeking new opportunities.
Maxwell Dee
Maxwell Dee
23 June 2025
Tryptamine Therapeutics has secured ethics approval to begin a pioneering clinical trial of TRP-8803, an IV-infused psilocin treatment, targeting adult patients with Binge Eating Disorder. The trial aims to evaluate safety and efficacy, with initial results expected by the end of 2025.
Ada Torres
Ada Torres
23 June 2025